Lithium may slow progression of amyotrophic lateral sclerosis, but further study is needed

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 16, 2008, Pages

  Bedlack, Richard S ^a   Maragakis, Nicholas ^b   Heiman Patterson, Terry ^c  

^a DUKE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; PLACEBO; LITHIUM DERIVATIVE;

AIRWAY PRESSURE; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; DISEASE COURSE; HUMAN; LETTER; PATIENT SELECTION; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; SURVIVAL; NOTE;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; LITHIUM COMPOUNDS;

EID: 43149113695     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801762105     Document Type: Letter

References (3)

1. Fornai F, et al. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 105.2052-2057.
2. International Committee of Medical Journal Editors (2004). Clinical trial registration: A statement from the international committee of medical journal editors. Ann Int Med 141:476-477.
3. Gordon PH, et al. (2007). Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomized trial. Lancet Neurol 6:1045-1053.